BofA Securities upgraded Trupanion from Neutral to Buy and set a new price target of $49.00 from $35.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/23/2025 | $57.00 | Neutral → Overweight | Piper Sandler |
| 7/19/2024 | Outperform | William Blair | |
| 5/16/2024 | $35.00 → $49.00 | Neutral → Buy | BofA Securities |
| 5/8/2023 | $72.00 → $32.00 | Buy → Neutral | BofA Securities |
| 9/21/2022 | $77.00 | Buy | Jefferies |
| 8/4/2022 | $80.00 → $69.00 | Overweight → Neutral | Piper Sandler |
| 2/24/2022 | $129.00 → $118.00 | Neutral → Buy | B of A Securities |
| 12/8/2021 | $126.00 → $183.00 | Overweight | Piper Sandler |
144 - TRUPANION, INC. (0001371285) (Subject)
144 - TRUPANION, INC. (0001371285) (Subject)
10-Q - TRUPANION, INC. (0001371285) (Filer)
4 - TRUPANION, INC. (0001371285) (Issuer)
3/A - TRUPANION, INC. (0001371285) (Issuer)
4 - TRUPANION, INC. (0001371285) (Issuer)
SC 13G/A - TRUPANION, INC. (0001371285) (Subject)
SC 13G/A - TRUPANION, INC. (0001371285) (Subject)
SC 13G/A - TRUPANION, INC. (0001371285) (Subject)
Boehringer Ingelheim, Mars Science & Diagnostics and leading pet, public health and animal health authorities to join Advisory Board Collaboration to address emerging pet and public health threats to protect pets and peopleEarly detection potential has global pet and public health benefits SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs in North America, in partnership with the Centers for Disease Control and Prevention (CDC), and leading pet industry partners, today announced the formation of a collaborative Advisory Board to launch a Pet & Public Health Early Warning & Detection System. The Advisory B
SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced that its Board of Directors has unanimously approved the appointment of Margi Tooth to Chief Executive Officer, effective August 1, 2024. Tooth's appointment to CEO marks the culmination of a multi-year, board-led process. Tooth will also continue as President and hold the dual titles of CEO and President. Additionally, Tooth is anticipated to be appointed to Trupanion's Board of Directors during its July meeting. Trupanion's founder and outgoing CEO Darryl Rawlings will continue to serve in the role of Chair of the Board, in which capacity he
A global entrepreneur with decades of experience growing insurance businesses worldwide, including pet insurance brands in Australia and South AfricaEnthoven associated with Tarmac DLTFM LTD., holder of 8.6% of Trupanion outstanding shares SEATTLE, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP) has appointed Richard Enthoven, Director at PetSure Australia and Hollard Holdings Australia, as an independent director to the Company's Board of Directors, effective today. Tarmac DLTFM LTD. ("Tarmac"), an Enthoven family investment entity, purchased shares of Trupanion in the open market between July and October of 2023, amounting to approximately 8.6% of Trupanion's outsta
4/A - TRUPANION, INC. (0001371285) (Issuer)
4 - TRUPANION, INC. (0001371285) (Issuer)
Piper Sandler upgraded Trupanion from Neutral to Overweight and set a new price target of $57.00
William Blair initiated coverage of Trupanion with a rating of Outperform
BofA Securities upgraded Trupanion from Neutral to Buy and set a new price target of $49.00 from $35.00 previously
SEATTLE, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2024 fourth quarter and full year after the market closes on Wednesday, February 19, 2025. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast discussing results, guidance and management observations will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. A slide presentation will also be available on the site.
SEATTLE, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the third quarter ended September 30, 2024. "Q3 was a very strong financial quarter for the company, combining consistent revenue growth with a 66% year-over-year increase in subscription discretionary profit," said Margi Tooth, Chief Executive Officer and President of Trupanion. "This outperformance was driven by aligning the cost of veterinary care with member pricing, resulting in the achievement of our target value proposition of 71%. Trupanion is solving a bigger problem today than ever before, and after generat
SEATTLE, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2024 third quarter after the market closes on Wednesday, October 30, 2024. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast (including a slide presentation) discussing results, guidance and management observations will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. Participants can access the conferen
SEATTLE, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2024 fourth quarter and full year after the market closes on Wednesday, February 19, 2025. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast discussing results, guidance and management observations will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. A slide presentation will also be available on the site.
SEATTLE, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs in North America, was honored today by Built In and its 2025 Best Places To Work Awards. Trupanion earned a spot on Built In's Best Places to Work in Seattle and 100 Best Large Places to Work in Seattle. This achievement marks the 6th consecutive year Trupanion has been recognized among Seattle's top workplaces by Built In. "It is a delight to see Trupanion named one of the Best Places to Work in Seattle for the 6th consecutive year," says Trupanion CEO, Margi Tooth. "At Trupanion, we are dedicated to fostering a work environment that empowers them to gro
NEW YORK, Dec. 17, 2024 /PRNewswire/ -- URvet Care, a trusted provider of exceptional veterinary care, is proud to announce its collaboration with Trupanion, a leading provider of pet medical insurance for cats and dogs. This collaboration allows URvet Care to help pet parents through Trupanion's innovative Vet Direct Pay solution. Trupanion is the only pet insurer in North America capable of paying their portion of a client's invoice directly to the treating hospital at the time of checkout – in less than a minute, on average. With this partnership, URvet Care joins more than